Global Information
회사소개 | 문의

보조인공심장(VAD) : 의료기기 파이프라인 평가

Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 06월 상품 코드 217932
페이지 정보 영문 193 Pages
가격
US $ 4,000 ₩ 4,573,600 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,147,200 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,720,800 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


보조인공심장(VAD) : 의료기기 파이프라인 평가 Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018
발행일 : 2018년 06월 페이지 정보 : 영문 193 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 보조인공심장(VAD) 시장 , 주요 파이프라인 제품(의료기기)과 임상시험의 진행 상황 조사, 제품 특성 비교 분석(임상시험 진행 단계별), 주요 기업의 개요 및 대표적 제품, 최근 시장 동향(자본거래·사업 제휴 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 보조인공심장(VAD) 개요

제3장 현재 임상시험중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 부문별
  • 파이프라인 제품 : 영역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 현재 진행중인 임상시험

제4장 보조인공심장 : 각 기업에서 현재 임상시험중인 파이프라인 제품

  • 보조인공심장 기업 : 임상시험 단계별 파이프라인 제품
  • 보조인공심장 : 임상시험 단계별 파이프라인 제품

제5장 보조인공심장 기업·제품의 개요

  • Abiomed, Inc.
    • 파이프라인 제품 및 진행중인 임상시험 개요
  • Biophan Technologies, Inc.
  • BioVentrix Inc
  • Braile Biomedica Ltda
  • Calon Cardio-Technology Ltd
  • CardiacAssist Inc
  • CARDIAnove
  • Cardio Vox, Inc.
  • CardioKinetix Inc
  • CardioPlus, Inc.
  • Carnegie Mellon University
  • Cleveland Clinic Hospital
  • Cleveland Heart Inc
  • CorAssist Cardiovascular Ltd
  • Corinnova Inc
  • CorWave
  • Drexel University
  • DUALIS MedTech GmbH
  • Duke University
  • Ension, Inc.
  • Evaheart Inc
  • Everheart Systems, LLC
  • FineHeart
  • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
  • Gold Medical Technologies, Inc.
  • HeartWare International Inc
  • Indiana University
  • Jarvik Heart Inc
  • LaunchPoint Technologies, Inc.
  • Leviticus Cardio Ltd
  • Levram Medical Systems Ltd
  • Lonestar Heart Inc
  • Mayo Clinic US
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • MyoCardioCare, Inc.
  • NeoCardial Technologies, LLC
  • Nipro Corp
  • NuPulse Inc
  • Penn State Milton S Hershey Medical Center
  • PlugMed Heart SAS
  • Procyrion
  • Purdue University
  • QRS Diagnostic LLC
  • ReliantHeart, Inc.
  • Rutgers The State University of New Jersey
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical Inc
  • Sunshine Heart Company, Pty. Ltd.
  • SynCardia Systems, Inc.
  • Teleflex Inc
  • The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development
  • The Pennsylvania State University
  • Thoratec Corp
  • Tokyo Medical and Dental University Company
  • Stem Cell Inc
  • University of Louisville
  • University of Michigan
  • University of Minnesota
  • University of Zurich
  • Vadovations, Inc.
  • Vienna University of Technology
  • Windmill Cardiovascular Systems, Inc.
  • Yale University

제6장 보조인공심장 시장 : 최근 동향

제7장 제안

도표

KSA 16.12.28

List of Tables

1.1 List of Tables

  • Table 1: Ventricular Assist Devices - Pipeline Products by Stage of Development 14
  • Table 2: Ventricular Assist Devices - Pipeline Products by Segment 15
  • Table 3: Ventricular Assist Devices - Pipeline Products by Territory 16
  • Table 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path 17
  • Table 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date 18
  • Table 6: Ventricular Assist Devices - Ongoing Clinical Trials 19
  • Table 7: Ventricular Assist Devices Companies - Pipeline Products by Stage of Development 20
  • Table 8: Ventricular Assist Devices - Pipeline Products by Stage of Development 23
  • Table 9: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 10: Impella BTR - Product Status 26
  • Table 11: Impella BTR - Product Description 27
  • Table 12: Impella CP (Cardiac Power) - Product Status 27
  • Table 13: Impella CP (Cardiac Power) - Product Description 27
  • Table 14: Impella ECP - Product Status 28
  • Table 15: Impella ECP - Product Description 28
  • Table 16: Impella RP - Product Status 28
  • Table 17: Impella RP - Product Description 29
  • Table 18: Next Generation Impella CP - STEMI - Product Status 29
  • Table 19: Next Generation Impella CP - STEMI - Product Description 29
  • Table 20: Abiomed Inc - Ongoing Clinical Trials Overview 30
  • Table 21: Impella RP - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry 31
  • Table 22: Impella CP (Cardiac Power) - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry 32
  • Table 23: Impella CP (Cardiac Power) - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial 32
  • Table 24: Impella CP (Cardiac Power) - Pulsecath mechanicaL Support Evaluation (PULSE) - Trial 32
  • Table 25: Next Generation Impella CP - STEMI - Door to Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study 33
  • Table 26: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 27: PliCath HF - Product Status 34
  • Table 28: PliCath HF - Product Description 34
  • Table 29: BioVentrix Inc - Ongoing Clinical Trials Overview 35
  • Table 30: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 36
  • Table 31: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 32: Blood Pump - Product Status 37
  • Table 33: Blood Pump - Product Description 37
  • Table 34: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 35: Calon MiniVAD - Product Status 38
  • Table 36: Calon MiniVAD - Product Description 38
  • Table 37: CathVAD - Product Status 39
  • Table 38: CathVAD - Product Description 39
  • Table 39: MicroVAD - Product Status 39
  • Table 40: MicroVAD - Product Description 39
  • Table 41: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 42: Pediatric pVAD - Product Status 40
  • Table 43: Pediatric pVAD - Product Description 40
  • Table 44: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 45: CARDIAnove Pump - Product Status 41
  • Table 46: CARDIAnove Pump - Product Description 41
  • Table 47: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 48: tVAD - Heart Failure - Product Status 42
  • Table 49: tVAD - Heart Failure - Product Description 42
  • Table 50: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 51: PediPump - Product Status 43
  • Table 52: PediPump - Product Description 43
  • Table 53: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 54: SmartHeart LVAD - Product Status 44
  • Table 55: SmartHeart LVAD - Product Description 44
  • Table 56: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 57: CORolla - Product Status 45
  • Table 58: CORolla - Product Description 45
  • Table 59: ImCardia - Product Status 46
  • Table 60: ImCardia - Product Description 46
  • Table 61: CorAssist Cardiovascular Ltd - Ongoing Clinical Trials Overview 47
  • Table 62: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction 48
  • Table 63: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility 48
  • Table 64: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 65: CardiacSTAR - Bridge To Decision - Product Status 49
  • Table 66: CardiacSTAR - Bridge To Decision - Product Description 49
  • Table 67: CardiacSTAR - Bridge To Recovery - Product Status 50
  • Table 68: CardiacSTAR - Bridge To Recovery - Product Description 50
  • Table 69: CardiacSTAR - Bridge To Transplant - Product Status 50
  • Table 70: CardiacSTAR - Bridge To Transplant - Product Description 51
  • Table 71: CardiacSTAR - Destination Therapy - Product Status 51
  • Table 72: CardiacSTAR - Destination Therapy - Product Description 51
  • Table 73: CardiacSTAR - Heart Rehabilitation - Product Status 52
  • Table 74: CardiacSTAR - Heart Rehabilitation - Product Description 52
  • Table 75: EpicHeart - Soft Robotic Heart Device - Product Status 52
  • Table 76: EpicHeart - Soft Robotic Heart Device - Product Description 53
  • Table 77: CorWave Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 78: CorWave Neptune - Product Status 54
  • Table 79: CorWave Neptune - Product Description 54
  • Table 80: CorWave Nemo - Product Status 55
  • Table 81: CorWave Nemo - Product Description 55
  • Table 82: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 83: Intravascular Blood Pump - Product Status 56
  • Table 84: Intravascular Blood Pump - Product Description 56
  • Table 85: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 86: CAREFLOW Pump - Product Status 57
  • Table 87: CAREFLOW Pump - Product Description 57
  • Table 88: Duke University Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 89: Para-Aortic Blood Pump - Product Status 58
  • Table 90: Para-Aortic Blood Pump - Product Description 58
  • Table 91: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 92: CardioFlowPQ - Product Status 59
  • Table 93: CardioFlowPQ - Product Description 59
  • Table 94: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 95: EVAHEART Left Ventricular Assist System - Product Status 60
  • Table 96: EVAHEART Left Ventricular Assist System - Product Description 60
  • Table 97: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 98: Fully Implantable Left Ventricular Assist Device - Product Status 61
  • Table 99: Fully Implantable Left Ventricular Assist Device - Product Description 61
  • Table 100: FineHeart Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 101: ICOMS - Product Status 62
  • Table 102: ICOMS - Product Description 62
  • Table 103: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 104: Ventricular Assist Device - Product Status 63
  • Table 105: Ventricular Assist Device - Product Description 63
  • Table 106: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 107: Soft Robotic Sleeve - Product Status 64
  • Table 108: Soft Robotic Sleeve - Product Description 64
  • Table 109: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 110: BiVAD - Product Status 65
  • Table 111: BiVAD - Product Description 65
  • Table 112: Fully Implantable VAD System - Product Status 66
  • Table 113: Fully Implantable VAD System - Product Description 66
  • Table 114: HeartWare IV-VAD - Product Status 66
  • Table 115: HeartWare IV-VAD - Product Description 66
  • Table 116: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Status 67
  • Table 117: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Description 67
  • Table 118: Levacor Rotary VAD - Product Status 67
  • Table 119: Levacor Rotary VAD - Product Description 68
  • Table 120: Longhorn - Product Status 68
  • Table 121: Longhorn - Product Description 68
  • Table 122: MiFlow VAD - Product Status 69
  • Table 123: MiFlow VAD - Product Description 69
  • Table 124: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Status 69
  • Table 125: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Description 70
  • Table 126: VCAN Trans-Mitral - Product Status 70
  • Table 127: VCAN Trans-Mitral - Product Description 70
  • Table 128: HeartWare International Inc - Ongoing Clinical Trials Overview 71
  • Table 129: Miniaturized Ventricular Assist Device (MVAD) Pump - Multi Center, Prospective, Non-randomized, Single-arm Trial Evaluating the Clinical Safety and Performance of the HeartWare MVAD System for the Treatment of Advanced Heart Failure 72
  • Table 130: Indiana University Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 131: Bi-Conical Heart Pump - Product Status 73
  • Table 132: Bi-Conical Heart Pump - Product Description 73
  • Table 133: Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 134: Jarvik 15mm LVAD System - Product Status 74
  • Table 135: Jarvik 15mm LVAD System - Product Description 74
  • Table 136: Jarvik 2000 Heart - Bridge To Transplant - Product Status 75
  • Table 137: Jarvik 2000 Heart - Bridge To Transplant - Product Description 75
  • Table 138: Jarvik 2000 Heart - Destination Therapy - Product Status 75
  • Table 139: Jarvik 2000 Heart - Destination Therapy - Product Description 76
  • Table 140: Jarvik Heart Inc - Ongoing Clinical Trials Overview 77
  • Table 141: Jarvik 2000 Heart - Destination Therapy - Evaluation of the Jarvik 2000 Left Ventricular Assist System with Post-auricular Connector--Destination Therapy Study 78
  • Table 142: LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 143: Pediaflow Pediatric VAD - Product Status 79
  • Table 144: Pediaflow Pediatric VAD - Product Description 79
  • Table 145: Streamliner VAD - Product Status 80
  • Table 146: Streamliner VAD - Product Description 80
  • Table 147: Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 148: Coplanar Energy Transfer System - Product Status 81
  • Table 149: Coplanar Energy Transfer System - Product Description 81
  • Table 150: Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 151: LEVRAM-Ventricular Assist Device - Product Status 82
  • Table 152: LEVRAM-Ventricular Assist Device - Product Description 82
  • Table 153: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 154: HVAD System - Thoracotomy - Product Status 83

List of Figures

1.2 List of Figures

  • Figure 1: Ventricular Assist Devices - Pipeline Products by Stage of Development 14
  • Figure 2: Ventricular Assist Devices - Pipeline Products by Segment 15
  • Figure 3: Ventricular Assist Devices - Pipeline Products by Territory 16
  • Figure 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path 17
  • Figure 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date 18
  • Figure 6: Ventricular Assist Devices - Ongoing Clinical Trials 19

영문목차

GlobalData's Medical Devices sector report, "Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Ventricular Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ventricular Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ventricular Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ventricular Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ventricular Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 11

2 Introduction 12

  • 2.1 Ventricular Assist Devices Overview 12

3 Products under Development 13

  • 3.1 Ventricular Assist Devices - Pipeline Products by Stage of Development 13
  • 3.2 Ventricular Assist Devices - Pipeline Products by Segment 14
  • 3.3 Ventricular Assist Devices - Pipeline Products by Territory 15
  • 3.4 Ventricular Assist Devices - Pipeline Products by Regulatory Path 16
  • 3.5 Ventricular Assist Devices - Pipeline Products by Estimated Approval Date 17
  • 3.6 Ventricular Assist Devices - Ongoing Clinical Trials 18

4 Ventricular Assist Devices - Pipeline Products under Development by Companies 19

  • 4.1 Ventricular Assist Devices Companies - Pipeline Products by Stage of Development 19
  • 4.2 Ventricular Assist Devices - Pipeline Products by Stage of Development 22

5 Ventricular Assist Devices Companies and Product Overview 25

  • 5.1 Abiomed Inc Company Overview 25
  • 5.2 BioVentrix Inc Company Overview 33
  • 5.3 Braile Biomedica Ltda Company Overview 36
  • 5.4 Calon Cardio-Technology Ltd Company Overview 37
  • 5.5 CardiacAssist Inc Company Overview 39
  • 5.6 CARDIAnove Company Overview 40
  • 5.7 Carnegie Mellon University Company Overview 41
  • 5.8 Cleveland Clinic Hospital Company Overview 42
  • 5.9 Cleveland Heart Inc Company Overview 43
  • 5.10 CorAssist Cardiovascular Ltd Company Overview 44
  • 5.11 Corinnova Inc Company Overview 48
  • 5.12 CorWave Company Overview 53
  • 5.13 Drexel University Company Overview 55
  • 5.14 DUALIS MedTech GmbH Company Overview 56
  • 5.15 Duke University Company Overview 57
  • 5.16 Ension, Inc. Company Overview 58
  • 5.17 Evaheart Inc Company Overview 59
  • 5.18 Everheart Systems, LLC Company Overview 60
  • 5.19 FineHeart Company Overview 61
  • 5.20 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 62
  • 5.21 Harvard University Company Overview 63
  • 5.22 HeartWare International Inc Company Overview 64
  • 5.23 Indiana University Company Overview 72
  • 5.24 Jarvik Heart Inc Company Overview 73
  • 5.25 LaunchPoint Technologies, Inc. Company Overview 78
  • 5.26 Leviticus Cardio Ltd Company Overview 80
  • 5.27 Levram Medical Systems Ltd Company Overview 81
  • 5.28 Medtronic plc Company Overview 82
  • 5.29 Michigan Critical Care Consultants, Inc. Company Overview 83
  • 5.30 MyoCardioCare, Inc. Company Overview 84
  • 5.31 Myotech, LLC (Inactive) Company Overview 86
  • 5.32 NeoCardial Technologies, LLC Company Overview 87
  • 5.33 Nipro Corp Company Overview 88
  • 5.34 Novapump GmbH Company Overview 89
  • 5.35 NuPulseCV Company Overview 91
  • 5.36 Pennsylvania State University Company Overview 92
  • 5.37 Perfusion Solution Inc Company Overview 93
  • 5.38 PlugMed Heart SAS Company Overview 95
  • 5.39 Procyrion Company Overview 96
  • 5.40 Purdue University Company Overview 97
  • 5.41 ReliantHeart, Inc. Company Overview 98
  • 5.42 Rutgers The State University of New Jersey Company Overview 103
  • 5.43 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 104
  • 5.44 St. Jude Medical LLC Company Overview 105
  • 5.45 Sunshine Heart Company, Pty. Ltd. Company Overview 107
  • 5.46 Syncardia Systems LLC Company Overview 108
  • 5.47 Teleflex Inc Company Overview 110
  • 5.48 Terumo Corp Company Overview 111
  • 5.49 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview 112
  • 5.50 Thoratec Corp Company Overview 113
  • 5.51 Tokyo Medical and Dental University Company Overview 120
  • 5.52 U.S. Stem Cell Inc Company Overview 121
  • 5.53 University of Louisville Company Overview 122
  • 5.54 University of Michigan Company Overview 123
  • 5.55 Vadovations, Inc. Company Overview 124
  • 5.56 Windmill Cardiovascular Systems, Inc. Company Overview 125
  • 5.57 Yale University Company Overview 126

6 Ventricular Assist Devices- Recent Developments 128

  • 6.1 May 22, 2018: Abbott Recalls the HeartMate 3 Left Ventricular Assist System Due to Potential Malfunction that may Lead to Graft Occlusion 128
  • 6.2 May 15, 2018: Micron Solutions Reports 2018 First Quarter Results 128
  • 6.3 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration 129
  • 6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 130
  • 6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 130
  • 6.6 May 09, 2018: U.S. Stem Cell Reports First Quarter Results 131
  • 6.7 May 04, 2018: Abbott Implements Corrective Action for HeartMate 3 Heart Pump 132
  • 6.8 May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 132
  • 6.9 May 03, 2018: Teleflex Reports First Quarter 2018 Results 133
  • 6.10 Apr 30, 2018: Procyrion Appoints Clinical Operations Pro Tara Burt As Associate Director Of Clinical Affairs 136
  • 6.11 Apr 16, 2018: USRM Reports 2017 Financial Results 136
  • 6.12 Apr 10, 2018: Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study 137
  • 6.13 Apr 09, 2018: Medtronic to Unveil Additional Clinical Data on HVAD System at ISHLT 2018 138
  • 6.14 Apr 04, 2018: Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg 139
  • 6.15 Apr 02, 2018: Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor 140
  • 6.16 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 141
  • 6.17 Mar 26, 2018: Micron Solutions Reports 2017 Fourth Quarter and Year End Results 142
  • 6.18 Mar 21, 2018: Procyrion Names Elisabeth Neely Senior Vice President Of Clinical And Regulatory Affairs, Formerly With Abbott 143
  • 6.19 Mar 14, 2018: Baylor College of Medicine approved for $489,000 in funding for LVAD treatment decision support 144
  • 6.20 Mar 13, 2018: UR Medicine Leads U.S. in Minimally Invasive Surgery for Newest LVAD Heart Pump 145
  • 6.21 Mar 11, 2018: New Long-term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's Heartmate 3 Heart Pump 147
  • 6.22 Mar 01, 2018: Palmetto Health is first facility in state to implant HeartMate 3 LVAD outside of research trials 148
  • 6.23 Feb 26, 2018: Successful Outcomes Seen in First-in-Human Trial of NuPulseCV''s Intravascular Ventricular Assist System (iVAS) 149
  • 6.24 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 149
  • 6.25 Feb 14, 2018: Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures 152
  • 6.26 Feb 13, 2018: Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock 153
  • 6.27 Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 154
  • 6.28 Feb 13, 2018: Carmat: 2017 Annual Results 155
  • 6.29 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 157
  • 6.30 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 157
  • 6.31 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 158
  • 6.32 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 159
  • 6.33 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 161
  • 6.34 Jan 04, 2018: Apollo Hospitals, Hyderguda successfully implanted the LVAD Heart Mate 3 to give a new lease of life for a 70-year-old heart failure patient. 161
  • 6.35 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 162

7 Appendix 189

  • 7.1 Methodology 189
  • 7.2 About GlobalData 192
  • 7.3 Contact Us 192
  • 7.4 Disclaimer 192
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research